Metformin use did not improve survival of patients with pancreatic ductal adenocarcinoma (PDAC) in a retrospective cohort study, according to data presented at the AACR Annual Meeting 2015, April 18-22.

READ FULL ARTICLE Curated publisher From Medical Express